Kiora Pharmaceuticals
Claudia Gregorio-King has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Claudia currently holds the position of Senior Director, Clinical Development at Kiora Pharmaceuticals, Inc. Prior to this, they served as a Clinical Consultant and Vice President, Clinical Product Development at AdAlta Ltd. Claudia also worked as an Operations Consultant and Vice President of Operations at Prescient Therapeutics. Additionally, Claudia has held roles such as Research and Development Program Manager at Cell Care Australia, Clinical Operations Manager at Cytomatrix Pty Ltd/NOHLA Therapeutics, and Regulatory Affairs Consultant & Clinical Project Manager at Clinical Network Services. Claudia has also worked as a Clinical Project Manager at i3 Research and held the role of Research and Development Program Manager at CNSBio Pty Ltd/Relevare Pharmaceuticals. Claudia began their career as a Post-Doctoral Fellow at Peter MacCallum Cancer Centre and later at Barwon Health. Overall, they bring a wealth of experience and expertise in clinical development, operations, research and development, and project management.
Claudia Gregorio-King holds a Ph.D. in Biomedical Science from Deakin University, which they obtained between 1997 and 2000. Prior to that, they completed their BSc.(Hons) in Physiology/Molecular Biology at the University of Melbourne between 1991 and 1993. Claudia then pursued a Post Graduate Diploma in Intellectual Property Law at the University of Melbourne from 2008 to 2010.
This person is not in any offices
Kiora Pharmaceuticals
Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye.